drugset / Trial / NCT00198562
Hypertension Control Based on Home Blood Pressure
Phase 4
Unknown
2600 enrolled
Ministry of Health, Labour and Welfare, Japan
Japan Cardiovascular Research Foundation · collab
RandomizedFactorialOpen-labelTreatment
Summary
The aim of this trial is to study the effects of antihypertensive therapy based on home systolic blood pressure (BP) with different target levels using two classes of drugs. The HOSP study is a multicenter, prospective, randomized, open, blinded endpoint study. The study subjects are 40-79 years old hypertensive patients. After a 4 weeks of baseline period, subjects are randomly assigned to (1) modest control group (morning home BP \<140 mmHg) or (2) strict control group (morning home BP \<130 mmHg), and to (a) amlodipine group or (b) losartan group. Additional antihypertensive drugs can be used if home BP is not controlled. Home BP is measured in the early morning and late evening. The participants will be followed up for 5 years.
Timeline
- Start
- 2000-04
- Primary completion
- 2012-03
- Completion
- 2012-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Amlodipine | Other / unclassified | 2.5 mg | — |
| Comparator | Amlodipine | Other / unclassified | 10 mg | — |
| Comparator | Losartan | Other / unclassified | 25 mg | — |
| Comparator | Losartan | Other / unclassified | 100 mg | — |